Compare Piramal Healthcare with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs NOVARTIS - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES NOVARTIS PIRAMAL ENTERPRISES/
NOVARTIS
 
P/E (TTM) x 13.7 478.0 2.9% View Chart
P/BV x 0.9 27.7 3.1% View Chart
Dividend Yield % 2.0 1.6 123.3%  

Financials

 PIRAMAL ENTERPRISES   NOVARTIS
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
NOVARTIS
Mar-18
PIRAMAL ENTERPRISES/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs3,303758 435.7%   
Low Rs1,797579 310.3%   
Sales per share (Unadj.) Rs716.5228.4 313.7%  
Earnings per share (Unadj.) Rs79.731.7 251.1%  
Cash flow per share (Unadj.) Rs107.932.8 329.4%  
Dividends per share (Unadj.) Rs28.0010.00 280.0%  
Dividend yield (eoy) %1.11.5 73.4%  
Book value per share (Unadj.) Rs1,477.5297.1 497.2%  
Shares outstanding (eoy) m184.4524.69 747.1%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.62.9 121.6%   
Avg P/E ratio x32.021.1 151.9%  
P/CF ratio (eoy) x23.620.4 115.8%  
Price / Book Value ratio x1.72.2 76.7%  
Dividend payout %35.131.5 111.5%   
Avg Mkt Cap Rs m470,29216,505 2,849.3%   
No. of employees `0007.80.7 1,170.7%   
Total wages/salary Rs m22,5041,445 1,557.0%   
Avg. sales/employee Rs Th16,899.48,441.3 200.2%   
Avg. wages/employee Rs Th2,877.72,163.6 133.0%   
Avg. net profit/employee Rs Th1,879.91,173.1 160.3%   
INCOME DATA
Net Sales Rs m132,1535,639 2,343.6%  
Other income Rs m3,1281,718 182.0%   
Total revenues Rs m135,2817,357 1,838.8%   
Gross profit Rs m66,290-63 -106,063.4%  
Depreciation Rs m5,20225 20,559.3%   
Interest Rs m44,09755 79,742.1%   
Profit before tax Rs m20,1191,575 1,277.2%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,611792 1,087.8%   
Profit after tax Rs m14,701784 1,876.1%  
Gross profit margin %50.2-1.1 -4,525.6%  
Effective tax rate %42.850.3 85.2%   
Net profit margin %11.113.9 80.1%  
BALANCE SHEET DATA
Current assets Rs m122,7429,522 1,289.1%   
Current liabilities Rs m310,8103,296 9,429.9%   
Net working cap to sales %-142.3110.4 -128.9%  
Current ratio x0.42.9 13.7%  
Inventory Days Days2337 63.0%  
Debtors Days Days3928 136.6%  
Net fixed assets Rs m116,90446 254,139.6%   
Share capital Rs m369123 298.9%   
"Free" reserves Rs m272,1617,213 3,773.2%   
Net worth Rs m272,5307,336 3,714.8%   
Long term debt Rs m270,1960-   
Total assets Rs m856,26111,105 7,710.4%  
Interest coverage x1.529.5 4.9%   
Debt to equity ratio x1.00-  
Sales to assets ratio x0.20.5 30.4%   
Return on assets %6.97.6 90.9%  
Return on equity %5.410.7 50.5%  
Return on capital %12.422.2 55.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m15,20061 25,083.2%   
Fx outflow Rs m4,8893,630 134.7%   
Net fx Rs m10,312-3,570 -288.9%   
CASH FLOW
From Operations Rs m-115,9751,610 -7,203.8%  
From Investments Rs m-8,265687 -1,203.1%  
From Financial Activity Rs m107,525-2,677 -4,017.4%  
Net Cashflow Rs m-16,650-380 4,386.2%  

Share Holding

Indian Promoters % 52.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 4.0 2.0 200.0%  
FIIs % 26.6 1.6 1,662.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 21.5 76.7%  
Shareholders   93,274 41,647 224.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  BIOCON   STERLING BIOTECH  NATCO PHARMA  

Compare PIRAMAL ENTERPRISES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 87 Points Higher; Telecom and Auto Stocks Witness Buying(Closing)

Indian share markets ended their trading session marginally higher. On the sectoral front, gains were seen in the telecom sector and auto sector.

Related Views on News

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound?(Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Foreign Money is Chasing Indian Stocks Once Again(The 5 Minute Wrapup)

Oct 4, 2019

Around Rs 75 billion poured into the Indian stock market in the month of September.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Oct 14, 2019 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 5-YR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS